Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies

Annals of Neurology

Volumn 77, Issue 3, 2015, Pages 381-398

  Peng, Xiaoyu ^a   Hughes, Ethan G ^a   Moscato, Emilia H ^a   Parsons, Thomas D ^b   Dalmau, Josep ^a,c   Balice Gordon, Rita J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AMPA RECEPTOR ANTIBODY; ANTIBODY; EPITOPE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; IMMUNOGLOBULIN G; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 1; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ELECTROPHYSIOLOGICAL PROCEDURES; EMBRYO; ENCEPHALITIS; HIPPOCAMPAL NEURONAL CULTURE; HUMAN; HUMAN CELL; INTERNALIZATION; NERVE CELL PLASTICITY; NONHUMAN; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL; RAT; SYNAPSE; WESTERN BLOTTING; WHOLE CELL PATCH CLAMP; ANIMAL; CELL CULTURE; CYTOLOGY; FEMALE; HIPPOCAMPUS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NERVE CELL; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIBODIES; CELLS, CULTURED; ENCEPHALITIS; FEMALE; HIPPOCAMPUS; HUMANS; MIDDLE AGED; NEURONAL PLASTICITY; NEURONS; RATS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 84923769479     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24293     Document Type: Article

References (53)

1. Lancaster E, Dalmau J. Neuronal autoantigens - pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012; 8: 380-390.
2. Moscato EH, Jain A, Peng X, et al. Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci 2010; 32: 298-309.
3. Sansing LH, Tüzün E, Ko MW, et al. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007; 3: 291-296.
4. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7: 1091-1098.
5. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65: 424-434.
6. Hollmann M, Hartley M, Heinemann S. Ca21 permeability of KAAMPA-gated glutamate receptor channels depends on subunit composition. Science 1991; 252: 851-853.
7. Wisden W, Seeburg PH. Mammalian ionotropic glutamate receptors. Curr Opin Neurobiol 1993; 3: 291-298.
8. Lu W, Shi Y, Jackson AC, et al. Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron 2009; 62: 254-268.
9. Wenthold RJ, Petralia RS, Blahos J Jr, Niedzielski AS. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 1996; 16: 1982-1989.
10. Palmer CL, Cotton L, Henley JM. The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol Rev 2005; 57: 253-277.
11. Shepherd JD, Huganir RL. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 2007; 23: 613-643.
12. Sprengel R. Role of AMPA receptors in synaptic plasticity. Cell Tissue Res 2006; 326: 447-455.
13. Zamanillo D, Sprengel R, Hvalby O, et al. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 1999; 284: 1805-1811.
14. Meng Y, Zhang Y, Jia Z. Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3. Neuron 2003; 39: 163-176.
15. Granger AJ, Shi Y, Lu W, et al. LTP requires a reserve pool of glutamate receptors independent of subunit type. Nature 2013; 493: 495-500.
16. Jia Z, Agopyan N, Miu P, et al. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 1996; 17: 945-956.
17. Kaech S, Banker G. Culturing hippocampal neurons. Nat Protoc 2006; 1: 2406-2415.
18. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J. Neurosci 2010; 30: 5866-5875.
19. Ehlers MD Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 2000; 28: 511-525.
20. Peng X, Parsons TD, Balice-Gordon RJ. Determinants of synaptic strength vary across an axon arbor. J Neurophysiol 2012; 107: 2430-2441.
21. Bergsman J, Krueger S, Fitzsimonds R. Automated criteria-based selection and analysis of fluorescent synaptic puncta. J Neurosci Methods 2006; 152: 32-39.
22. Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 2013; 33: 18161-18174.
23. Bassani S, Folci A, Zapata J, Passafaro M. AMPAR trafficking in synapse maturation and plasticity. Cell Mol Life Sci 2013; 70: 4411-4430.
24. Chen L, Chetkovich DM, Petralia RS, et al. Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature 2000; 408: 936-943.
25. Schnell E, Sizemore M, Karimzadegan S, et al. Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc Natl Acad Sci U S A 2002; 99: 13902-13907.
26. Gleichman AJ, Panzer JA, Baumann BH, et al. Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis. Ann Clin Transl Neurol 2014; 1: 180-189.
27. Wilcox KS, Fitzsimonds RM, Johnson B, Dichter MA. Glycine regulation of synaptic NMDA receptors in hippocampal neurons. J Neurophysiol 1996; 76: 3415-3424.
28. Kilman V, van Rossum MCW, Turrigiano GG. Activity deprivation reduces miniature IPSC amplitude by decreasing the number of postsynaptic GABA(A) receptors clustered at neocortical synapses. J Neurosci 2002; 22: 1328-1337.
29. Hartman KN, Pal SK, Burrone J, Murthy VN. Activity-dependent regulation of inhibitory synaptic transmission in hippocampal neurons. Nat Neurosci 2006; 9: 642-649.
30. Swanwick CC, Murthy NR, Kapur J. Activity-dependent scaling of GABAergic synapse strength is regulated by brain-derived neurotrophic factor. Mol Cell Neurosci 2006; 31: 481-492.
31. Rannals MD, Kapur J. Homeostatic strengthening of inhibitory synapses is mediated by the accumulation of GABA(A) receptors. J Neurosci 2011; 31: 17701-17712.
32. Peng Y-R, Zeng S-Y, Song H-L, et al. Postsynaptic spiking homeostatically induces cell-autonomous regulation of inhibitory inputs via retrograde signaling. J Neurosci 2010; 30: 16220-16231.
33. Turrigiano G. Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu Rev Neurosci 2011; 34: 89-103.
34. Burrone J, O'Byrne M, Murthy VN. Multiple forms of synaptic plasticity triggered by selective suppression of activity in individual neurons. Nature 2002; 420: 414-418.
35. Turrigiano GG, Leslie KR, Desai NS, et al. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 1998; 391: 892-896.
36. Gerlai R, Henderson JT, Roder JC, Jia Z. Multiple behavioral anomalies in GluR2 mutant mice exhibiting enhanced LTP. Behav Brain Res 1998; 95: 37-45.
37. Ferrante A, Thong YH. Antibody induced capping and endocytosis of surface antigens in Naegleria fowleri. Int J Parasitol 1979; 9: 599-601.
38. Santoso S, Zimmermann U, Neppert J, Mueller-Eckhardt C. Receptor patching and capping of platelet membranes induced by monoclonal antibodies. Blood 1986; 67: 343-349.
39. Drachman DB Myasthenia gravis. N Engl J Med 1994; 330: 1797-1810.
40. Drachman DB, Angus CW, Adams RN, et al. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 1978; 298: 1116-1122.
41. Gleichman AJ, Spruce LA, Dalmau J, et al. Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci 2012; 32: 11082-11094.
42. Tzartos SJ, Barkas T, Cung MT, et al. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev 1998; 163: 89-120.
43. Sobolevsky AI, Rosconi MP, Gouaux E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 2009; 462: 745-756.
44. Chuntharapai A, Dodge K, Grimmer K, et al. Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J Immunol 2001; 166: 4891-4898.
45. Lee SH, Simonetta A, Sheng M. Subunit rules governing the sorting of internalized AMPA receptors in hippocampal neurons. Neuron 2004; 43: 221-236.
46. Van der Sluijs P, Hoogenraad CC. New insights in endosoma dynamics and AMPA receptor trafficking. Semin Cell Dev Bio 2011; 22: 499-505.
47. Fernandez-Monreal M, Brown TC, Royo M, Esteban JA. The balance between receptor recycling and trafficking toward lysosomes determines synaptic strength during long-term depression. J Neurosci 2012; 32: 13200-13205.
48. Baulac S, Huberfeld G, Gourfinkel-An I, et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 2001; 28: 46-48.
49. Bowser DN, Wagner DA, Czajkowski C, et al. Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy. Proc Natl Acad Sci U S A 2002; 99: 15170-15175.
50. Thind KK, Yamawaki R, Phanwar I, et al. Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy. J Comp Neurol 2010; 518: 647-667.
51. Escayg A, Goldin AL Sodium channel SCN1A and epilepsy: mutations and mechanisms. Epilepsia 2010; 51: 1650-1658.
52. Gibbs JW, Sombati S, DeLorenzo RJ, Coulter DA. Physiologica and pharmacological alterations in postsynaptic GABA(A) receptor function in a hippocampal culture model of chronic spontaneous seizures. J Neurophysiol 1997; 77: 2139-2152.
53. Menuz K, Nicoll RA. Loss of inhibitory neuron AMPA receptors contributes to ataxia and epilepsy in stargazer mice. J Neurosci 2008; 28: 10599-10603.